Globeflex Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Globeflex Capital’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-268,448	Closed	-$521K	–	615
2016 Q4	$521K	Buy	268,448 +245,800	+1,085%	+$889K	0.13%	248
2016 Q3	$141K	Sell	22,648 -48	-0.2%	-$296	0.04%	352
2016 Q2	$102K	Buy	22,696 +3,469	+18%	+$22.6K	0.03%	348
2016 Q1	$202K	Hold	19,227	–	–	0.05%	319
2015 Q4	$567K	Sell	19,227 -5,874	-23%	-$178K	0.15%	213
2015 Q3	$793K	Buy	25,101 +25,086	+167,240%	+$1.2M	0.17%	215
2015 Q2	$1K	Sell	15 -3	-17%	-$212	﹤0.01%	490
2015 Q1	$2K	Buy	18 +8	+80%	+$762	﹤0.01%	408
2014 Q4	$1K	Sell	10 -1	-9%	-$95	﹤0.01%	508
2014 Q3	$1K	Sell	11 -25	-69%	-$1.97K	﹤0.01%	534
2014 Q2	$3K	Buy	+36	New	+$2.21K	﹤0.01%	436

Other funds holding PTX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Globeflex Capital's PTX Position: Q1 2017 in Review

Globeflex Capital sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2017, closing a stake of 268,448 shares — an estimated $521K sold.

Globeflex Capital first reported a position in PTX in Q2 2014 and held it in 11 quarters. The position peaked at $793K in Q3 2015. 31 funds tracked by Wall St. Rank hold PTX as of Q1 2017.

Globeflex Capital reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Globeflex Capital sold 268,448 Pernix Therapeutics Holdings, Inc. shares in Q1 2017, an estimated $521K.
Globeflex Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 11 quarters.
Globeflex Capital's Pernix Therapeutics Holdings, Inc. position peaked at $793K in Q3 2015.
31 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2017.

Based on Globeflex Capital's 13F filing for Q1 2017, filed 12 May 2017.